Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene Challenge in Alcohol Dependent Participants (NALCUE)
NCT02372318Phase 1Terminated
- Sponsor
- Central Institute of Mental Health
- Start
- Apr 2015
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nalmefene in alcohol use disorder (AUD), sponsored by Central Institute of Mental Health. Primary endpoint: Difference in cue-induced brain activation between nalmefene and placebo at 2 hours. Started Apr 2015; status: terminated.
02
Drugs
nalmefene
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02372318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372318.